Patients in UK get early access to GSK’s Jemperli
It concerns the treatment being combined with platinum-containing chemotherapy
Read Moreby John Pinching | Jul 11, 2023 | News | 0
It concerns the treatment being combined with platinum-containing chemotherapy
Read Moreby Selina McKee | May 27, 2020 | News | 0
The drug will be provided to the NHS free of charge by Gilead via the UK’s early access to medicines scheme
Read Moreby Selina McKee | May 23, 2018 | News | 0
Clinigen says it has partnered with Mitsubishi Tanabe Pharma to initiate a Managed Access Program in Europe for edaravone, an intravenous treatment for amyotrophic lateral sclerosis (ALS).
Read Moreby Selina McKee | Mar 22, 2018 | News | 0
Akcea Therapeutics’ volanesorsen will be available to eligible patients in the UK before it is officially licensed in the EU, having been granted entry to the country’s Early Access to Medicines Scheme.
Read Moreby Selina McKee | Oct 10, 2017 | News | 0
Akcea Therapeutics’s volanesorsen has been granted a Promising Innovative Medicine designation by the Medicines and Healthcare products Regulatory Agency for the treatment of familial chylomicronaemia syndrome, a rare genetic lipid disorder.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479